Australia markets close in 6 hours 9 minutes

Scinai Immunotherapeutics Ltd. (SCNI)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.4661-0.0029 (-0.62%)
At close: 04:00PM EDT
0.4750 +0.01 (+1.91%)
After hours: 05:40PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
6,017
5,765
3,249
16,004
Selling general and administrative
4,888
5,296
7,625
5,018
Total operating expenses
10,905
11,061
10,862
-2,281
Operating income or loss
-10,905
-11,061
-10,862
2,281
Interest expense
-
-
3,486
348.9294
Total other income/expenses net
-
-
1,839
-3,305
Income before tax
-9,286
-5,796
-8,206
-1,385
Income from continuing operations
-9,286
-5,796
-8,206
-1,385
Net income
-9,286
-5,796
-8,206
-1,385
Net income available to common shareholders
-9,286
-5,796
-8,206
-1,385
Basic EPS
-4.40
-4.00
-8.00
-1.24
Diluted EPS
-4.40
-4.00
-8.00
-1.24
Basic average shares
3,641
1,885
1,411
1,108
Diluted average shares
3,641
1,885
1,411
1,108